Short Interest in NLS Pharmaceutics Ltd. (NASDAQ:NLSPW) Expands By 1,188.9%

NLS Pharmaceutics Ltd. (NASDAQ:NLSPW) saw a large increase in short interest during the month of December. As of December 31st, there was short interest totalling 11,600 shares, an increase of 1,188.9% from the December 15th total of 900 shares. Based on an average trading volume of 37,600 shares, the days-to-cover ratio is currently 0.3 days.

NLS Pharmaceutics Stock Down 22.8 %

Shares of NLS Pharmaceutics stock traded down $0.00 during trading hours on Monday, hitting $0.01. The company’s stock had a trading volume of 43,948 shares, compared to its average volume of 58,978. NLS Pharmaceutics has a 12 month low of $0.01 and a 12 month high of $0.10. The stock has a 50 day moving average of $0.01 and a 200 day moving average of $0.02.

About NLS Pharmaceutics

NLS Pharmaceutics AG, a clinical-stage biopharmaceutical company, engages in the discovery and development of therapies for patients with rare and complex central nervous system disorders. The company is focusing on the development of treatments for narcolepsy, idiopathic hypersomnia, and other rare sleep disorders, as well as neurodevelopmental disorders, such as attention deficit hyperactivity disorder (ADHD).